Available to SourceHuman Prescription DrugRespiratory

Synagis (Palivizumab)

50 mg/.5mL · Injection Solution

By Swedish Orphan Biovitrum AB (publ)

Palivizumab · Injectable Solution · 50 mg/.5mL · IM

NDC: 66658-230
Route: Intramuscular
Therapeutic class: Antibodies, Monoclonal [CS], Fusion Protein Inhibitors [MoA], Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody
Marketing category: BLA

Package sizes

.5 mL in 1 VIAL, SINGLE-DOSE (66658-230-01)NDC 66658-230-01Available to Order

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Respiratory

See all →

Synagis (Palivizumab)

Package sizes

Additional information

Request this medication.

Related in Respiratory

Amoeba-Chord

Daytime Cold and Flu Relief

Daytime Cold and Flu Relief

Acetaminohpen…